3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
8
Metastatic Castration-resistant Prostate Cancer
1
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
1
Glioma
1
Glioblastoma
1
Disease
1
Astrocytoma
1
Interventions
proxalutamide
1
Pluvicto
1
Androgen Receptor Antagonists
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
×
Pluvicto
×
Clear all
NCT06943495
2025-09-09
PRODIGY-2
CHU de Quebec-Universite Laval
Phase 1
Recruiting
60 enrolled